Long-term disease stability assessed by the expanded disability status scale in patients treated with cladribine tablets in the CLARITY and CLARITY extension studies

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2020
This article has no abstract
Epistemonikos ID: f496ca07945ad36f2cd991ba6a297686fe106828
First added on: Mar 31, 2022